Trends in adoption of Wingspan stentsBMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g1552 (Published 19 February 2014) Cite this as: BMJ 2014;348:g1552
- Aakriti Gupta, internal medicine resident1,
- Harlan Krumholz, professor of medicine (cardiology)2
- 1Yale-New Haven Hospital, New Haven, CT 06511, USA
- 2Yale New Haven Hospital Center for Outcomes Research and Evaluation, New Haven, CT, USA
Two recent BMJ articles have criticised the US Food and Drug Administration for approving the Wingspan stent used for intracranial stenting (ICS) to prevent recurrent stroke despite insufficient evidence of its effectiveness.1 2 They also draw attention to the FDA’s inadequate response to recent evidence from the SAMMPRIS randomised controlled trial against the use of ICS in these patients.
We share …